EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Acute unilateral mydriasis following direct ocular exposure to powdered ipratropium bromide: A case report

Kübra Özata Gündoğdu, Aleyna Nur Yetim İlkis, Sevde Nur Akyüz Altun, Mehmet Fatih Çakmak

Indian Journal of Ophthalmology - Case Reports · 2026-07 · 6 (3) · 745-748

DOI: 10.4103/ijo.ijo_2805_25 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Indian Journal of Ophthalmology - Case Reports, online erschienen am 24.07.2026. Verfasst von Kübra Özata Gündoğdu und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To report a unique case of acute unilateral mydriasis caused by direct ocular exposure to powdered ipratropium bromide and to highlight the importance of differentiating pharmacologic from neurologic or traumatic etiologies. A 30-year-old male presented with blurred vision in the left eye and noticeable pupil asymmetry. Examination revealed a left pupil of 6 mm with no light or near response, while the right pupil measured 3 mm. Ocular motility, fundus, and neurological examinations were normal. Cranial imaging showed no abnormalities. The patient reported occupational exposure to powdered ipratropium bromide. A diagnosis of pharmacologic mydriasis secondary to direct ocular contact was made. The anisocoria resolved spontaneously within 36 hours after avoidance of further exposure. Pharmacologic unilateral mydriasis due to ipratropium bromide is rare, typically reported following inhalation. Our case is unique in that direct eye contact, rather than inhalation, induced transient, reversible anisocoria. Differentiation from neurologic or traumatic causes is essential; pharmacologic mydriasis usually presents as isolated anisocoria with preserved ocular motility and normal fundus and can be confirmed using the pilocarpine test. Awareness of occupational or accidental ocular exposure can prevent unnecessary imaging and interventions. Direct ocular exposure to anticholinergic agents such as ipratropium bromide can cause acute, reversible unilateral mydriasis. Thorough history-taking and careful clinical evaluation are key to accurate diagnosis and appropriate management.

Zitieren

APA

Gündoğdu, K. Ö., İlkis, A. N. Y., Altun, S. N. A., & Çakmak, M. F. (2026). Acute unilateral mydriasis following direct ocular exposure to powdered ipratropium bromide: A case report. Indian Journal of Ophthalmology - Case Reports, 6(3), 745-748. https://doi.org/10.4103/ijo.ijo_2805_25

Vancouver

Gündoğdu KÖ, İlkis ANY, Altun SNA, Çakmak MF. Acute unilateral mydriasis following direct ocular exposure to powdered ipratropium bromide: A case report. Indian Journal of Ophthalmology - Case Reports. 2026;6(3):745-748. doi:10.4103/ijo.ijo_2805_25

BibTeX
@article{Gndodu2026,
  author = {Gündoğdu, Kübra Özata and İlkis, Aleyna Nur Yetim and Altun, Sevde Nur Akyüz and Çakmak, Mehmet Fatih},
  title = {Acute unilateral mydriasis following direct ocular exposure to powdered ipratropium bromide: A case report},
  journal = {Indian Journal of Ophthalmology - Case Reports},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {745--748},
  doi = {10.4103/ijo.ijo_2805_25}
}
Kostenlos starten →